3.26.1 html 192 424 1 false 62 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.beyondspringpharma.com/20251231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.beyondspringpharma.com/20251231/role/statement-condensed-consolidated-balance-sheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.beyondspringpharma.com/20251231/role/statement-condensed-consolidated-balance-sheets-parentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.beyondspringpharma.com/20251231/role/statement-condensed-consolidated-statements-of-comprehensive-income-loss Condensed Consolidated Statements of Comprehensive Income (Loss) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Shareholders' Deficit Sheet http://www.beyondspringpharma.com/20251231/role/statement-condensed-consolidated-statements-of-shareholders-deficit- Condensed Consolidated Statements of Shareholders' Deficit Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.beyondspringpharma.com/20251231/role/statement-condensed-consolidated-statements-of-cash-flows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995443 - Disclosure - Award Timing Disclosure Sheet http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure Award Timing Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 9 false false R10.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 10 false false R11.htm 995550 - Disclosure - Note 1 - Nature of the Business Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-1-nature-of-the-business Note 1 - Nature of the Business Notes 11 false false R12.htm 995551 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 12 false false R13.htm 995552 - Disclosure - Note 3 - Discontinued Operations Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-3-discontinued-operations Note 3 - Discontinued Operations Notes 13 false false R14.htm 995553 - Disclosure - Note 5 - Collaboration Agreements Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-5-collaboration-agreements Note 5 - Collaboration Agreements Notes 14 false false R15.htm 995554 - Disclosure - Note 5 - Property and Equipment, Net Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-5-property-and-equipment-net Note 5 - Property and Equipment, Net Notes 15 false false R16.htm 995555 - Disclosure - Note 6 - Income Taxes Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes Note 6 - Income Taxes Notes 16 false false R17.htm 995556 - Disclosure - Note 7 - Share-based Compensation Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation Note 7 - Share-based Compensation Notes 17 false false R18.htm 995557 - Disclosure - Note 8 - Employee Defined Contribution Plan Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-8-employee-defined-contribution-plan- Note 8 - Employee Defined Contribution Plan Notes 18 false false R19.htm 995558 - Disclosure - Note 9 - Restricted Net Assets Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-9-restricted-net-assets Note 9 - Restricted Net Assets Notes 19 false false R20.htm 995559 - Disclosure - Note 10 - Leases Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-10-leases Note 10 - Leases Notes 20 false false R21.htm 995560 - Disclosure - Note 11 - Supplemental Balance Sheet Information Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-11-supplemental-balance-sheet-information Note 11 - Supplemental Balance Sheet Information Notes 21 false false R22.htm 995561 - Disclosure - Note 12 - Noncontrolling Interests Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-12-noncontrolling-interests- Note 12 - Noncontrolling Interests Notes 22 false false R23.htm 995562 - Disclosure - Note 13 - Commitments and Contingencies Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-13-commitments-and-contingencies Note 13 - Commitments and Contingencies Notes 23 false false R24.htm 995563 - Disclosure - Note 14 - Segment Reporting and Geographic Information Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-14-segment-reporting-and-geographic-information Note 14 - Segment Reporting and Geographic Information Notes 24 false false R25.htm 995564 - Disclosure - Note 15 - Related Party Transactions Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-15-related-party-transactions- Note 15 - Related Party Transactions Notes 25 false false R26.htm 995565 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.beyondspringpharma.com/20251231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.beyondspringpharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies 26 false false R27.htm 995566 - Disclosure - Note 1 - Nature of the Business (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-1-nature-of-the-business-tables Note 1 - Nature of the Business (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-1-nature-of-the-business 27 false false R28.htm 995567 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies 28 false false R29.htm 995568 - Disclosure - Note 3 - Discontinued Operations (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-3-discontinued-operations-tables Note 3 - Discontinued Operations (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-3-discontinued-operations 29 false false R30.htm 995569 - Disclosure - Note 5 - Property and Equipment, Net (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-5-property-and-equipment-net-tables Note 5 - Property and Equipment, Net (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-5-property-and-equipment-net 30 false false R31.htm 995570 - Disclosure - Note 6 - Income Taxes (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-tables Note 6 - Income Taxes (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes 31 false false R32.htm 995571 - Disclosure - Note 7 - Share-based Compensation (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation-tables Note 7 - Share-based Compensation (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation 32 false false R33.htm 995572 - Disclosure - Note 10 - Leases (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-10-leases-tables Note 10 - Leases (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-10-leases 33 false false R34.htm 995573 - Disclosure - Note 11 - Supplemental Balance Sheet Information (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-11-supplemental-balance-sheet-information-tables Note 11 - Supplemental Balance Sheet Information (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-11-supplemental-balance-sheet-information 34 false false R35.htm 995574 - Disclosure - Note 14 - Segment Reporting and Geographic Information (Tables) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-14-segment-reporting-and-geographic-information-tables Note 14 - Segment Reporting and Geographic Information (Tables) Tables http://www.beyondspringpharma.com/20251231/role/statement-note-14-segment-reporting-and-geographic-information 35 false false R36.htm 995575 - Disclosure - Note 1 - Nature of the Business (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-1-nature-of-the-business-details-textual Note 1 - Nature of the Business (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-1-nature-of-the-business-tables 36 false false R37.htm 995576 - Disclosure - Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-1-nature-of-the-business-schedule-of-subsidiaries-details Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Details 37 false false R38.htm 995577 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-tables 38 false false R39.htm 995578 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-useful-life-of-property-plant-and-equipment-details Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Details 39 false false R40.htm 995579 - Disclosure - Note 3 - Discontinued Operations (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-3-discontinued-operations-details-textual Note 3 - Discontinued Operations (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-3-discontinued-operations-tables 40 false false R41.htm 995580 - Disclosure - Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-3-discontinued-operations-summary-of-discontinued-operations-details Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) Details 41 false false R42.htm 995581 - Disclosure - Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) (Parentheticals) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-3-discontinued-operations-summary-of-discontinued-operations-details-parentheticals Note 3 - Discontinued Operations - Summary of Discontinued Operations (Details) (Parentheticals) Details 42 false false R43.htm 995582 - Disclosure - Note 5 - Collaboration Agreements (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-5-collaboration-agreements-details-textual Note 5 - Collaboration Agreements (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-5-collaboration-agreements 43 false false R44.htm 995583 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-5-property-and-equipment-net-details-textual Note 5 - Property and Equipment, Net (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-5-property-and-equipment-net-tables 44 false false R45.htm 995584 - Disclosure - Note 5 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-5-property-and-equipment-net-schedule-of-property-and-equipment-details Note 5 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Details 45 false false R46.htm 995585 - Disclosure - Note 6 - Income Taxes (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-details-textual Note 6 - Income Taxes (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-tables 46 false false R47.htm 995586 - Disclosure - Note 6 - Income Taxes - Components of Losses Before Income Taxes (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-components-of-losses-before-income-taxes-details Note 6 - Income Taxes - Components of Losses Before Income Taxes (Details) Details 47 false false R48.htm 995587 - Disclosure - Note 6 - Income Taxes - Provision for Income Expense (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-provision-for-income-expense-details Note 6 - Income Taxes - Provision for Income Expense (Details) Details 48 false false R49.htm 995588 - Disclosure - Note 6 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-reconciliation-of-income-tax-expenses-details Note 6 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Details 49 false false R50.htm 995589 - Disclosure - Note 6 - Income Taxes - Deferred Tax Assets (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-deferred-tax-assets-details Note 6 - Income Taxes - Deferred Tax Assets (Details) Details 50 false false R51.htm 995590 - Disclosure - Note 6 - Income Taxes - Unrecognized Tax Benefits (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-6-income-taxes-unrecognized-tax-benefits-details Note 6 - Income Taxes - Unrecognized Tax Benefits (Details) Details 51 false false R52.htm 995591 - Disclosure - Note 7 - Share-based Compensation (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation-details-textual Note 7 - Share-based Compensation (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation-tables 52 false false R53.htm 995592 - Disclosure - Note 7 - Share-based Compensation - Restricted Share Activities (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation-restricted-share-activities-details Note 7 - Share-based Compensation - Restricted Share Activities (Details) Details 53 false false R54.htm 995593 - Disclosure - Note 7 - Share-based Compensation - Options Activities (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation-options-activities-details Note 7 - Share-based Compensation - Options Activities (Details) Details 54 false false R55.htm 995594 - Disclosure - Note 7 - Share-based Compensation - Fair Value Assumptions (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation-fair-value-assumptions-details Note 7 - Share-based Compensation - Fair Value Assumptions (Details) Details 55 false false R56.htm 995595 - Disclosure - Note 7 - Share-based Compensation - Share-based Compensation Expense (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-7-sharebased-compensation-sharebased-compensation-expense-details Note 7 - Share-based Compensation - Share-based Compensation Expense (Details) Details 56 false false R57.htm 995596 - Disclosure - Note 8 - Employee Defined Contribution Plan (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-8-employee-defined-contribution-plan-details-textual Note 8 - Employee Defined Contribution Plan (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-8-employee-defined-contribution-plan- 57 false false R58.htm 995597 - Disclosure - Note 9 - Restricted Net Assets (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-9-restricted-net-assets-details-textual Note 9 - Restricted Net Assets (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-9-restricted-net-assets 58 false false R59.htm 995598 - Disclosure - Note 10 - Leases (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-10-leases-details-textual Note 10 - Leases (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-10-leases-tables 59 false false R60.htm 995599 - Disclosure - Note 10 - Lease - Maturities of Lease Liabilities (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-10-lease-maturities-of-lease-liabilities-details Note 10 - Lease - Maturities of Lease Liabilities (Details) Details 60 false false R61.htm 995600 - Disclosure - Note 10 - Lease - Operating Lease Disclosure (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-10-lease-operating-lease-disclosure-details Note 10 - Lease - Operating Lease Disclosure (Details) Details 61 false false R62.htm 995601 - Disclosure - Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Assets (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-11-supplemental-balance-sheet-information-other-noncurrent-assets-details Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Assets (Details) Details 62 false false R63.htm 995602 - Disclosure - Note 11 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-11-supplemental-balance-sheet-information-other-current-liabilities-details Note 11 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Details 63 false false R64.htm 995603 - Disclosure - Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Liabilities (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-11-supplemental-balance-sheet-information-other-noncurrent-liabilities-details Note 11 - Supplemental Balance Sheet Information - Other Noncurrent Liabilities (Details) Details 64 false false R65.htm 995604 - Disclosure - Note 12 - Noncontrolling Interests (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-12-noncontrolling-interests-details-textual Note 12 - Noncontrolling Interests (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-12-noncontrolling-interests- 65 false false R66.htm 995605 - Disclosure - Note 14 - Segment Reporting and Geographic Information (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-14-segment-reporting-and-geographic-information-details-textual Note 14 - Segment Reporting and Geographic Information (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-14-segment-reporting-and-geographic-information-tables 66 false false R67.htm 995606 - Disclosure - Note 14 - Segment Reporting and Geographic Information - Segment Expenses (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-14-segment-reporting-and-geographic-information-segment-expenses-details Note 14 - Segment Reporting and Geographic Information - Segment Expenses (Details) Details 67 false false R68.htm 995607 - Disclosure - Note 14 - Segment Reporting and Geographic Information - Long Lived Assets by Geographic Area (Details) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-14-segment-reporting-and-geographic-information-long-lived-assets-by-geographic-area-details Note 14 - Segment Reporting and Geographic Information - Long Lived Assets by Geographic Area (Details) Details 68 false false R69.htm 995608 - Disclosure - Note 15 - Related Party Transactions (Details Textual) Sheet http://www.beyondspringpharma.com/20251231/role/statement-note-15-related-party-transactions-details-textual Note 15 - Related Party Transactions (Details Textual) Details http://www.beyondspringpharma.com/20251231/role/statement-note-15-related-party-transactions- 69 false false All Reports Book All Reports bysi-20251231.xsd bysi-20251231_cal.xml bysi-20251231_def.xml bysi-20251231_lab.xml bysi-20251231_pre.xml bysi20251231_10k.htm org.jpg pipeline-seed.jpg pipeline.jpg primout.jpg pvp1.jpg pvp2.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true